Biodesix, Inc. Common Stock (NASDAQ: BDSX) last traded at $23.99, down 4.04% on the session. The quote above updates while this page is open; the figures below are drawn from Biodesix, Inc. Common Stock’s own filings and are restated only when a new one is published.
Biodesix, Inc. Common Stock trades on NASDAQ under the ticker BDSX. Its market capitalisation is $253.12 million.
Valuation measures for Biodesix, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $253.12M |
|---|---|
| Enterprise value | $309.31M |
| Price / sales | 2.46 |
| Price / book | 27.68 |
| Beta | 0.94 |
Trailing-twelve-month figures tagged in Biodesix, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $102.94M |
|---|---|
| Net income (TTM) | -$27.76M |
| EPS (TTM) | -$3.11 |
| Operating margin | -20.02% |
| Return on equity | -303.61% |
| Cash | $30.00M |
Range and volume for BDSX over the past 52 weeks.
| 52-week high | $31.97 |
|---|---|
| 52-week low | $5.26 |
| Volume | 80.7K |
| Average volume | 99.5K |
| Previous close | $25.00 |
Invest a chosen dollar amount in Biodesix, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BDSX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.